Realistic Expectation Setting: While AOD-9604 enhances metabolic function and fat oxidation, it is not a standalone solution for body composition change
At the time of FDA-declared shortages, pharmacists can legally go on to make compounded versions when it comes to brand-name medications
Lilly's currently approved injection, Zepbound, and Novo Nordisk's Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly's oral obesity pill, Foundayo, has delivered about 11% weight loss
A triple agonist peptide is a single molecule that activates three different receptors at the same time
[3] But, the powerful compound has also been shown to enhance the body's uptake and transport of carnitine into cells